Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for PCRX

Stock Name	Pacira BioSciences, Inc.
Ticker	PCRX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US6951271005

Show aggregate PCRX holdings

News associated with PCRX

Pacira BioSciences, Inc. (NASDAQ:PCRX) Given Consensus Recommendation of “Moderate Buy” by Brokerages: Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) has earned a consensus rating of “Moderate Buy” from the six ratings firms that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year target price […] - 2025-08-12 04:43:07
Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Purchased by Zurcher Kantonalbank Zurich Cantonalbank: Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 20.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 16,519 shares of the company’s stock after buying an additional 2,848 shares during […] - 2025-08-08 04:56:50
Pacira BioSciences (NASDAQ:PCRX) Upgraded at Truist Financial: Truist Financial upgraded shares of Pacira BioSciences (NASDAQ:PCRX – Free Report) from a hold rating to a buy rating in a research report sent to investors on Friday, MarketBeat.com reports. The brokerage currently has $30.00 target price on the stock. Other equities analysts also recently issued research reports about the stock. HC Wainwright upped their […] - 2025-07-28 04:18:52
Bank of New York Mellon Corp Has $9.60 Million Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX): Bank of New York Mellon Corp decreased its position in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 2.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 386,149 shares of the company’s stock after selling 10,250 shares during the period. Bank […] - 2025-07-22 06:22:51
Louisiana State Employees Retirement System Cuts Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX): Louisiana State Employees Retirement System lessened its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 2.7% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 21,700 shares of the company’s stock after selling 600 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Pacira […] - 2025-07-21 05:18:53
Illinois Municipal Retirement Fund Has $629,000 Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX): Illinois Municipal Retirement Fund grew its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 24.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,318 shares of the company’s stock after acquiring an additional 5,011 […] - 2025-07-03 05:13:03
Robeco Institutional Asset Management B.V. Purchases 12,750 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX): Robeco Institutional Asset Management B.V. increased its position in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 18.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 82,694 shares of the company’s stock after buying an additional 12,750 shares during the quarter. Robeco […] - 2025-07-02 05:11:08
Pacira BioSciences, Inc. (NASDAQ:PCRX) Given Average Recommendation of “Hold” by Brokerages: Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) have been assigned an average rating of “Hold” from the nine research firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating […] - 2025-06-18 05:08:55
Head to Head Analysis: Pacira BioSciences (NASDAQ:PCRX) versus I-Mab (NASDAQ:IMAB): Pacira BioSciences (NASDAQ:PCRX – Get Free Report) and I-Mab (NASDAQ:IMAB – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings and analyst recommendations. Insider and Institutional Ownership 99.7% of Pacira BioSciences […] - 2025-06-18 03:08:45
California State Teachers Retirement System Has $812,000 Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX): California State Teachers Retirement System lessened its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 1.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 43,123 shares of the company’s stock after selling 835 shares during the quarter. California State Teachers […] - 2025-06-11 05:02:51
Friday's ETF with Unusual Volume: XPH: The SPDR S&P Pharmaceuticals ETF is seeing unusually high volume in afternoon trading Friday, with over 318,000 shares traded versus three month average volume of about 57,000. Shares of XPH were up about 1.5% on the day. Components of that ETF with the highest volume on - 2025-06-06 13:49:47
Two Sigma Investments LP Acquires 45,222 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX): Two Sigma Investments LP grew its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 65.1% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 114,682 shares of the company’s stock after buying an additional 45,222 shares during the quarter. Two Sigma Investments LP’s holdings in Pacira BioSciences were worth […] - 2025-06-02 05:08:57
State of Wyoming Boosts Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX): State of Wyoming lifted its position in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 8.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,566 shares of the company’s stock after purchasing an additional 487 shares during the quarter. State of Wyoming’s holdings […] - 2025-05-27 05:17:01
Graham Capital Management L.P. Sells 61,645 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX): Graham Capital Management L.P. decreased its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 83.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,268 shares of the company’s stock after selling 61,645 shares during the period. Graham Capital Management […] - 2025-05-19 05:27:01
Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Voya Investment Management LLC: Voya Investment Management LLC lowered its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 68.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,948 shares of the company’s stock after selling 29,901 shares during the quarter. Voya Investment Management […] - 2025-05-13 05:20:57
MetLife Investment Management LLC Acquires 1,471 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX): MetLife Investment Management LLC grew its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 5.6% in the 4th quarter, Holdings Channel.com reports. The fund owned 27,883 shares of the company’s stock after purchasing an additional 1,471 shares during the quarter. MetLife Investment Management LLC’s holdings in Pacira BioSciences were worth $525,000 as of […] - 2025-05-06 05:01:05
Marshall Wace LLP Has $803,000 Stake in Pacira BioSciences, Inc. (NASDAQ:PCRX): Marshall Wace LLP lessened its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 91.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 42,613 shares of the company’s stock after selling 482,336 shares during the period. Marshall Wace LLP’s holdings in […] - 2025-05-01 04:50:59
Legal & General Group Plc Sells 1,115 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX): Legal & General Group Plc decreased its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 0.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 125,849 shares of the company’s stock after selling 1,115 shares during the period. […] - 2025-04-25 05:08:57
Pacira BioSciences Announces Repurchase Authorization: (RTTNews) - Pacira BioSciences (PCRX) said its Board of Directors has authorized a share repurchase program of up to an aggregate of $300 million with respect to the common stock, replacing the prior authorization. The share repurchase authorization expires at the end of December - 2025-04-18 04:29:04
Sei Investments Co. Has $281,000 Position in Pacira BioSciences, Inc. (NASDAQ:PCRX): Sei Investments Co. trimmed its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 32.6% in the fourth quarter, HoldingsChannel reports. The firm owned 14,927 shares of the company’s stock after selling 7,231 shares during the period. Sei Investments Co.’s holdings in Pacira BioSciences were worth $281,000 as of its most recent SEC filing. […] - 2025-04-11 04:42:54
Wellington Management Group LLP Has $8.86 Million Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX): Wellington Management Group LLP lifted its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 3.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 470,191 shares of the company’s stock after purchasing an additional 15,542 shares during the quarter. Wellington Management Group LLP’s holdings in Pacira BioSciences were worth $8,858,000 […] - 2025-04-10 05:29:03
Pacira BioSciences (NASDAQ:PCRX) Shares Gap Up on Analyst Upgrade: Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) gapped up prior to trading on Tuesday after HC Wainwright raised their price target on the stock from $48.00 to $65.00. The stock had previously closed at $22.91, but opened at $27.60. HC Wainwright currently has a buy rating on the stock. Pacira BioSciences shares last traded […] - 2025-04-10 02:24:54
Corebridge Financial Inc. Reduces Position in Pacira BioSciences, Inc. (NASDAQ:PCRX): Corebridge Financial Inc. lowered its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 7.2% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 24,412 shares of the company’s stock after selling 1,904 shares during the period. Corebridge Financial Inc.’s holdings in Pacira BioSciences were worth $460,000 as of its most recent filing […] - 2025-04-09 05:27:01
Arrowstreet Capital Limited Partnership Sells 505,307 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX): Arrowstreet Capital Limited Partnership cut its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 43.8% during the 4th quarter, Holdings Channel.com reports. The fund owned 647,318 shares of the company’s stock after selling 505,307 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Pacira BioSciences were worth $12,195,000 as of […] - 2025-04-06 05:26:57
Thrivent Financial for Lutherans Has $672,000 Stake in Pacira BioSciences, Inc. (NASDAQ:PCRX): Thrivent Financial for Lutherans reduced its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 1.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 35,689 shares of the company’s stock after selling 534 shares during the period. Thrivent Financial for Lutherans’ holdings […] - 2025-04-03 04:16:46
Prudential Financial Inc. Decreases Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX): Prudential Financial Inc. reduced its position in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 42.8% in the 4th quarter, HoldingsChannel.com reports. The firm owned 254,168 shares of the company’s stock after selling 190,286 shares during the period. Prudential Financial Inc.’s holdings in Pacira BioSciences were worth $4,789,000 at the end of the most recent […] - 2025-04-01 05:34:48
Amundi Purchases 15,431 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX): Amundi raised its position in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 200.8% in the 4th quarter, Holdings Channel reports. The firm owned 23,114 shares of the company’s stock after buying an additional 15,431 shares during the period. Amundi’s holdings in Pacira BioSciences were worth $429,000 at the end of the most recent quarter. […] - 2025-03-21 05:59:07
Victory Capital Management Inc. Reduces Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX): Victory Capital Management Inc. trimmed its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 22.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 94,750 shares of the company’s stock after selling 27,478 shares during the quarter. Victory Capital […] - 2025-03-18 05:41:07
Illinois Municipal Retirement Fund Has $383,000 Stake in Pacira BioSciences, Inc. (NASDAQ:PCRX): Illinois Municipal Retirement Fund reduced its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 29.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 20,307 shares of the company’s stock after selling 8,510 shares during the period. […] - 2025-03-05 08:01:50
Principal Financial Group Inc. Has $4.86 Million Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX): Principal Financial Group Inc. boosted its holdings in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 4.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 257,733 shares of the company’s stock after buying an additional 10,306 shares during the quarter. Principal […] - 2025-03-04 06:14:50

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc PCRX holdings

Date	Number of PCRX Shares Held	Base Market Value of PCRX Shares	Local Market Value of PCRX Shares	Change in PCRX Shares Held	Change in PCRX Base Value	Current Price per PCRX Share Held	Previous Price per PCRX Share Held
2025-12-24 (Wednesday)	5,845	USD 152,087	USD 152,087	0	USD 1,637	USD 26.02	USD 25.7399
2025-12-23 (Tuesday)	5,845	USD 150,450	USD 150,450	-20	USD -2,157	USD 25.7399	USD 26.0199
2025-12-22 (Monday)	5,865	USD 152,607	USD 152,607	0	USD -1,936	USD 26.0199	USD 26.35
2025-12-19 (Friday)	5,865	USD 154,543	USD 154,543	0	USD 2,757	USD 26.35	USD 25.88
2025-12-18 (Thursday)	5,865	USD 151,786	USD 151,786	0	USD -3,930	USD 25.88	USD 26.55
2025-12-17 (Wednesday)	5,865	USD 155,716	USD 155,716	0	USD 2,170	USD 26.55	USD 26.1801
2025-12-16 (Tuesday)	5,865	USD 153,546	USD 153,546	0	USD -2,932	USD 26.1801	USD 26.68
2025-12-15 (Monday)	5,865	USD 156,478	USD 156,478	0	USD 2,287	USD 26.68	USD 26.29
2025-12-12 (Friday)	5,865	USD 154,191	USD 154,191	0	USD 3,285	USD 26.29	USD 25.7299
2025-12-11 (Thursday)	5,865	USD 150,906	USD 150,906	0	USD 3,225	USD 25.7299	USD 25.1801
2025-12-10 (Wednesday)	5,865	USD 147,681	USD 147,681	0	USD 2,405	USD 25.1801	USD 24.77
2025-12-09 (Tuesday)	5,865	USD 145,276	USD 145,276	0	USD 2,053	USD 24.77	USD 24.4199

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of PCRX by Blackrock for IE00B3VWM098

Show aggregate share trades of PCRX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-23 SELL -20 26.330 25.580 25.655 USD -513 23.37 Loss of -46 on sale
2025-12-03 SELL -100 24.810 23.870 23.964 USD -2,396 23.23 Loss of -74 on sale
2025-12-02 BUY 40 24.325 23.480 23.564 USD 943 23.22
2025-11-25 SELL -60 23.970 23.004 23.101 USD -1,386 23.21 Profit of 7 on sale
2025-11-24 SELL -60 23.470 22.510 22.606 USD -1,356 23.21 Profit of 37 on sale
2025-11-17 SELL -220 24.830 23.630 23.750 USD -5,225 23.20 Loss of -120 on sale
2025-11-12 SELL -20 24.300 23.850 23.895 USD -478 23.19 Loss of -14 on sale
2025-11-06 SELL -20 21.980 20.640 20.774 USD -415 23.21 Profit of 49 on sale
2025-11-05 SELL -200 22.700 21.605 21.714 USD -4,343 23.21 Profit of 300 on sale
2025-11-04 SELL -40 22.610 21.200 21.341 USD -854 23.22 Profit of 75 on sale
2025-11-03 SELL -40 22.740 21.372 21.509 USD -860 23.22 Profit of 69 on sale
2025-10-28 BUY 60 21.360 21.600 21.576 USD 1,295 23.27
2025-10-24 SELL -20 21.740 21.900 21.884 USD -438 23.28 Profit of 28 on sale
2025-10-15 BUY 120 23.450 23.510 23.504 USD 2,820 23.32
2025-10-02 BUY 20 24.580 25.460 25.372 USD 507 23.30
2025-09-30 BUY 40 25.770 25.980 25.959 USD 1,038 23.28
2025-08-21 SELL -20 25.390 25.660 25.633 USD -513 23.21 Loss of -48 on sale
2025-07-31 BUY 60 21.090 21.860 21.783 USD 1,307 23.21
2025-06-30 SELL -40 23.900 24.230 24.197 USD -968 23.28 Loss of -37 on sale
2025-06-25 SELL -20 23.910 24.500 24.441 USD -489 23.27 Loss of -23 on sale
2025-06-20 SELL -40 24.230 24.330 24.320 USD -973 23.24 Loss of -43 on sale
2025-05-23 BUY 20 25.750 26.240 26.191 USD 524 22.89
2025-05-19 SELL -20 26.150 26.410 26.384 USD -528 22.77 Loss of -72 on sale
2025-05-15 SELL -60 25.600 25.640 25.636 USD -1,538 22.72 Loss of -175 on sale
2025-05-12 SELL -20 25.090 26.260 26.143 USD -523 22.68 Loss of -69 on sale
2025-05-09 SELL -20 25.120 25.800 25.732 USD -515 22.66 Loss of -61 on sale
2025-04-30 SELL -20 26.900 27.080 27.062 USD -541 22.44 Loss of -92 on sale
2025-04-24 SELL -40 26.000 26.030 26.027 USD -1,041 22.28 Loss of -150 on sale
2025-04-17 SELL -20 24.650 25.080 25.037 USD -501 22.13 Loss of -58 on sale
2025-04-15 SELL -60 24.880 25.140 25.114 USD -1,507 22.07 Loss of -182 on sale
2025-04-14 SELL -60 24.970 25.350 25.312 USD -1,519 22.04 Loss of -196 on sale
2025-04-09 SELL -80 25.840 26.020 26.002 USD -2,080 21.95 Loss of -324 on sale
2025-04-07 SELL -140 22.910 24.170 24.044 USD -3,366 21.89 Loss of -301 on sale
2025-04-04 SELL -200 23.100 24.030 23.937 USD -4,787 21.88 Loss of -412 on sale
2025-03-31 BUY 20 24.850 25.200 25.165 USD 503 21.78
2025-03-19 SELL -40 24.280 24.330 24.325 USD -973 21.48 Loss of -114 on sale
2025-03-14 SELL -120 22.870 23.030 23.014 USD -2,762 21.41 Loss of -193 on sale
2025-03-13 SELL -40 22.690 23.500 23.419 USD -937 21.39 Loss of -81 on sale
2025-03-12 SELL -680 22.040 23.410 23.273 USD -15,826 21.38 Loss of -1,286 on sale
2025-03-07 SELL -40 23.370 24.230 24.144 USD -966 21.30 Loss of -114 on sale
2025-03-06 SELL -60 23.860 23.970 23.959 USD -1,438 21.26 Loss of -162 on sale
2025-03-03 SELL -20 22.960 24.140 24.022 USD -480 21.16 Loss of -57 on sale
2025-02-28 SELL -120 24.050 26.340 26.111 USD -3,133 21.12 Loss of -599 on sale
2025-02-26 SELL -20 25.480 26.690 26.569 USD -531 20.97 Loss of -112 on sale
2025-02-25 SELL -60 25.100 25.580 25.532 USD -1,532 20.90 Loss of -278 on sale
2025-02-18 BUY 100 26.440 26.500 26.494 USD 2,649 20.35
2025-02-13 BUY 20 26.530 27.270 27.196 USD 544 20.02
2025-02-12 BUY 20 27.130 27.300 27.283 USD 546 19.88
2025-02-11 BUY 60 27.250 27.360 27.349 USD 1,641 19.72
2025-02-06 BUY 180 26.260 27.170 27.079 USD 4,874 19.30
2025-01-27 BUY 20 25.660 25.770 25.759 USD 515 17.81
2024-12-30 BUY 100 18.940 19.700 19.624 USD 1,962 17.39
2024-12-06 BUY 80 19.270 19.400 19.387 USD 1,551 17.19
2024-12-05 BUY 20 18.670 19.540 19.453 USD 389 17.14
2024-12-04 BUY 100 19.090 19.490 19.450 USD 1,945 17.07
2024-11-29 BUY 100 16.910 17.010 17.000 USD 1,700 17.06
2024-11-27 BUY 80 16.640 17.000 16.964 USD 1,357 17.10
2024-11-26 BUY 20 16.780 17.340 17.284 USD 346 17.11
2024-11-21 BUY 100 17.380 17.550 17.533 USD 1,753 17.06
2024-11-20 BUY 60 17.030 17.270 17.246 USD 1,035 17.06
2024-11-18 BUY 240 16.640 16.820 16.802 USD 4,032 17.11
2024-11-12 BUY 160 16.800 17.540 17.466 USD 2,795 17.13
2024-11-08 BUY 100 17.240 18.340 18.230 USD 1,823 17.12
2024-11-07 BUY 300 17.700 18.220 18.168 USD 5,450 17.07
2024-11-06 BUY 40 17.670 18.300 18.237 USD 729 17.02
2024-10-31 BUY 20 16.600 16.920 16.888 USD 338 17.17
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-23	SELL	-20	26.330	25.580	25.655	USD -513	23.37 Loss of -46 on sale
2025-12-03	SELL	-100	24.810	23.870	23.964	USD -2,396	23.23 Loss of -74 on sale
2025-12-02	BUY	40	24.325	23.480	23.564	USD 943	23.22
2025-11-25	SELL	-60	23.970	23.004	23.101	USD -1,386	23.21 Profit of 7 on sale
2025-11-24	SELL	-60	23.470	22.510	22.606	USD -1,356	23.21 Profit of 37 on sale
2025-11-17	SELL	-220	24.830	23.630	23.750	USD -5,225	23.20 Loss of -120 on sale
2025-11-12	SELL	-20	24.300	23.850	23.895	USD -478	23.19 Loss of -14 on sale
2025-11-06	SELL	-20	21.980	20.640	20.774	USD -415	23.21 Profit of 49 on sale
2025-11-05	SELL	-200	22.700	21.605	21.714	USD -4,343	23.21 Profit of 300 on sale
2025-11-04	SELL	-40	22.610	21.200	21.341	USD -854	23.22 Profit of 75 on sale
2025-11-03	SELL	-40	22.740	21.372	21.509	USD -860	23.22 Profit of 69 on sale
2025-10-28	BUY	60	21.360	21.600	21.576	USD 1,295	23.27
2025-10-24	SELL	-20	21.740	21.900	21.884	USD -438	23.28 Profit of 28 on sale
2025-10-15	BUY	120	23.450	23.510	23.504	USD 2,820	23.32
2025-10-02	BUY	20	24.580	25.460	25.372	USD 507	23.30
2025-09-30	BUY	40	25.770	25.980	25.959	USD 1,038	23.28
2025-08-21	SELL	-20	25.390	25.660	25.633	USD -513	23.21 Loss of -48 on sale
2025-07-31	BUY	60	21.090	21.860	21.783	USD 1,307	23.21
2025-06-30	SELL	-40	23.900	24.230	24.197	USD -968	23.28 Loss of -37 on sale
2025-06-25	SELL	-20	23.910	24.500	24.441	USD -489	23.27 Loss of -23 on sale
2025-06-20	SELL	-40	24.230	24.330	24.320	USD -973	23.24 Loss of -43 on sale
2025-05-23	BUY	20	25.750	26.240	26.191	USD 524	22.89
2025-05-19	SELL	-20	26.150	26.410	26.384	USD -528	22.77 Loss of -72 on sale
2025-05-15	SELL	-60	25.600	25.640	25.636	USD -1,538	22.72 Loss of -175 on sale
2025-05-12	SELL	-20	25.090	26.260	26.143	USD -523	22.68 Loss of -69 on sale
2025-05-09	SELL	-20	25.120	25.800	25.732	USD -515	22.66 Loss of -61 on sale
2025-04-30	SELL	-20	26.900	27.080	27.062	USD -541	22.44 Loss of -92 on sale
2025-04-24	SELL	-40	26.000	26.030	26.027	USD -1,041	22.28 Loss of -150 on sale
2025-04-17	SELL	-20	24.650	25.080	25.037	USD -501	22.13 Loss of -58 on sale
2025-04-15	SELL	-60	24.880	25.140	25.114	USD -1,507	22.07 Loss of -182 on sale
2025-04-14	SELL	-60	24.970	25.350	25.312	USD -1,519	22.04 Loss of -196 on sale
2025-04-09	SELL	-80	25.840	26.020	26.002	USD -2,080	21.95 Loss of -324 on sale
2025-04-07	SELL	-140	22.910	24.170	24.044	USD -3,366	21.89 Loss of -301 on sale
2025-04-04	SELL	-200	23.100	24.030	23.937	USD -4,787	21.88 Loss of -412 on sale
2025-03-31	BUY	20	24.850	25.200	25.165	USD 503	21.78
2025-03-19	SELL	-40	24.280	24.330	24.325	USD -973	21.48 Loss of -114 on sale
2025-03-14	SELL	-120	22.870	23.030	23.014	USD -2,762	21.41 Loss of -193 on sale
2025-03-13	SELL	-40	22.690	23.500	23.419	USD -937	21.39 Loss of -81 on sale
2025-03-12	SELL	-680	22.040	23.410	23.273	USD -15,826	21.38 Loss of -1,286 on sale
2025-03-07	SELL	-40	23.370	24.230	24.144	USD -966	21.30 Loss of -114 on sale
2025-03-06	SELL	-60	23.860	23.970	23.959	USD -1,438	21.26 Loss of -162 on sale
2025-03-03	SELL	-20	22.960	24.140	24.022	USD -480	21.16 Loss of -57 on sale
2025-02-28	SELL	-120	24.050	26.340	26.111	USD -3,133	21.12 Loss of -599 on sale
2025-02-26	SELL	-20	25.480	26.690	26.569	USD -531	20.97 Loss of -112 on sale
2025-02-25	SELL	-60	25.100	25.580	25.532	USD -1,532	20.90 Loss of -278 on sale
2025-02-18	BUY	100	26.440	26.500	26.494	USD 2,649	20.35
2025-02-13	BUY	20	26.530	27.270	27.196	USD 544	20.02
2025-02-12	BUY	20	27.130	27.300	27.283	USD 546	19.88
2025-02-11	BUY	60	27.250	27.360	27.349	USD 1,641	19.72
2025-02-06	BUY	180	26.260	27.170	27.079	USD 4,874	19.30
2025-01-27	BUY	20	25.660	25.770	25.759	USD 515	17.81
2024-12-30	BUY	100	18.940	19.700	19.624	USD 1,962	17.39
2024-12-06	BUY	80	19.270	19.400	19.387	USD 1,551	17.19
2024-12-05	BUY	20	18.670	19.540	19.453	USD 389	17.14
2024-12-04	BUY	100	19.090	19.490	19.450	USD 1,945	17.07
2024-11-29	BUY	100	16.910	17.010	17.000	USD 1,700	17.06
2024-11-27	BUY	80	16.640	17.000	16.964	USD 1,357	17.10
2024-11-26	BUY	20	16.780	17.340	17.284	USD 346	17.11
2024-11-21	BUY	100	17.380	17.550	17.533	USD 1,753	17.06
2024-11-20	BUY	60	17.030	17.270	17.246	USD 1,035	17.06
2024-11-18	BUY	240	16.640	16.820	16.802	USD 4,032	17.11
2024-11-12	BUY	160	16.800	17.540	17.466	USD 2,795	17.13
2024-11-08	BUY	100	17.240	18.340	18.230	USD 1,823	17.12
2024-11-07	BUY	300	17.700	18.220	18.168	USD 5,450	17.07
2024-11-06	BUY	40	17.670	18.300	18.237	USD 729	17.02
2024-10-31	BUY	20	16.600	16.920	16.888	USD 338	17.17

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of PCRX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	52,099	0	123,269	42.3%
2025-09-18	43,539	0	107,413	40.5%
2025-09-17	54,189	0	246,306	22.0%
2025-09-16	82,421	0	239,735	34.4%
2025-09-15	159,073	2	307,671	51.7%
2025-09-12	205,225	0	267,650	76.7%
2025-09-11	80,513	0	176,033	45.7%
2025-09-10	116,502	0	171,706	67.8%
2025-09-09	112,414	0	188,831	59.5%
2025-09-08	105,261	0	236,751	44.5%
2025-09-05	75,537	0	131,849	57.3%
2025-09-04	149,745	7,159	289,312	51.8%
2025-09-03	97,245	0	200,543	48.5%
2025-09-02	75,560	0	288,063	26.2%
2025-08-29	110,380	0	181,051	61.0%
2025-08-28	205,314	2,000	326,738	62.8%
2025-08-27	195,950	0	334,509	58.6%
2025-08-26	80,181	0	135,869	59.0%
2025-08-25	65,949	0	124,996	52.8%
2025-08-22	49,762	0	102,734	48.4%
2025-08-21	80,876	0	126,100	64.1%
2025-08-20	56,330	0	101,290	55.6%
2025-08-19	75,737	0	218,361	34.7%
2025-08-18	152,697	0	401,062	38.1%
2025-08-15	125,600	0	367,483	34.2%
2025-08-14	93,376	0	314,283	29.7%
2025-08-13	66,587	0	288,603	23.1%
2025-08-12	131,601	17	215,996	60.9%
2025-08-11	87,101	0	177,377	49.1%
2025-08-08	318,236	0	459,607	69.2%
2025-08-07	223,165	0	394,083	56.6%
2025-08-06	500,520	0	674,653	74.2%
2025-08-05	136,316	0	282,392	48.3%
2025-08-04	240,686	0	344,051	70.0%
2025-08-01	450,666	0	517,524	87.1%
2025-07-31	124,402	0	322,818	38.5%
2025-07-30	121,888	0	287,261	42.4%
2025-07-29	44,574	0	85,432	52.2%
2025-07-28	84,917	0	184,799	46.0%
2025-07-25	137,007	43	238,974	57.3%
2025-07-24	47,747	0	98,609	48.4%
2025-07-23	48,178	0	113,468	42.5%
2025-07-22	66,252	2,839	149,873	44.2%
2025-07-21	111,788	0	294,458	38.0%
2025-07-18	99,442	795	177,714	56.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE